OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $37,000 | -19.6% | 86,470 | +4.9% | 0.00% | – |
| Q1 2016 | $46,000 | -78.8% | 82,470 | -19.9% | 0.00% | -100.0% |
| Q3 2015 | $217,000 | -56.2% | 102,970 | +3.0% | 0.00% | -50.0% |
| Q2 2015 | $495,000 | -39.0% | 99,970 | -3.4% | 0.00% | -50.0% |
| Q1 2015 | $811,000 | +224.4% | 103,530 | +155.6% | 0.00% | +100.0% |
| Q2 2014 | $250,000 | -7.7% | 40,497 | -2.9% | 0.00% | 0.0% |
| Q1 2014 | $271,000 | +19.9% | 41,691 | +3.9% | 0.00% | 0.0% |
| Q4 2013 | $226,000 | -12.1% | 40,141 | -4.3% | 0.00% | 0.0% |
| Q3 2013 | $257,000 | +2.0% | 41,941 | -2.7% | 0.00% | 0.0% |
| Q2 2013 | $252,000 | – | 43,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |